gtb-5550
gt biopharma
['gtb-5550']
gt biopharma poster presentation and mini oral session at esmo congress 2022 demonstrates gtb-5550 trike(r) ability to specifically target and efficiently kill multiple b7h3+ solid and hematologic malignancies 
We provide a balanced view on small cap biotech equities.